OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trials
Gui-Ling Chen, Yuan-zheng Qiu, Kaiqi Wu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
Gui-Ling Chen, Yuan-zheng Qiu, Kaiqi Wu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
Showing 8 citing articles:
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection
Young Hoon Hwang, Dal‐Hee Min, Wan Beom Park
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Young Hoon Hwang, Dal‐Hee Min, Wan Beom Park
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial
Chunhua Zhou, Yuan-zheng Qiu, Jianxin Wang, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Chunhua Zhou, Yuan-zheng Qiu, Jianxin Wang, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial
Yu‐Wen Su, Yuan-Zheng Qiu, Yuanhui Wang, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2438-2447
Closed Access | Times Cited: 3
Yu‐Wen Su, Yuan-Zheng Qiu, Yuanhui Wang, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2438-2447
Closed Access | Times Cited: 3
Impact of Immunosenescence on Vaccine Immune Responses and Countermeasures
Li Chen, Chengwei Shao, Jingxin Li, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1289-1289
Open Access | Times Cited: 2
Li Chen, Chengwei Shao, Jingxin Li, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1289-1289
Open Access | Times Cited: 2
COVID-19 vaccine updates for people under different conditions
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1
Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs
Hong Huo, Jinming Wang, Chan Li, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Hong Huo, Jinming Wang, Chan Li, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Comparison of inflammatory mediator cytokine responses to inactivated virus platform COVID-19 vaccines between elderly and young adult populations.
Taureni Hayati, Neng Tine Kartinah, Heri Wibowo, et al.
PubMed (2024) Vol. 4, Iss. 3, pp. e1380-e1380
Closed Access
Taureni Hayati, Neng Tine Kartinah, Heri Wibowo, et al.
PubMed (2024) Vol. 4, Iss. 3, pp. e1380-e1380
Closed Access
